SYRENasdaq United States
Market cap
$9.250 B
$104.91 +1.44%
Close of 7 Aug 2026
Revenue
$0.00
#3658 by revenue
Earnings
-$155.2M
Loss-making
Shares outstanding
88,173,762
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Spyre Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.